Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Petros Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2024 was -$1.80M. For fiscal 2024 it was -$1.80M. The highest annual figure on record is -$1.80M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$1.80M | – |
| FY2023 | Dec 31, 2023 | -$10.33M | – |
| FY2022 | Dec 31, 2022 | -$14.32M | – |
| FY2021 | Dec 31, 2021 | -$11.17M | – |
| FY2020 | Dec 31, 2020 | -$10.62M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $78.54K | – |
| Q3 FY2024 | Sep 30, 2024 | -$457.91K | – |
| Q2 FY2024 | Jun 30, 2024 | -$631.27K | – |
| Q1 FY2024 | Mar 31, 2024 | -$785.09K | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.24M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.64M | – |
| Q1 FY2023 | Mar 31, 2023 | -$482.50K | -144.7% |
| Q4 FY2022 | Dec 31, 2022 | -$3.18M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$100.55K | – |
| Q1 FY2022 | Mar 31, 2022 | $1.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.55M | – |
| Q1 FY2021 | Mar 31, 2021 | -$468.68K | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.64M | – |
| Q3 FY2020 | Sep 30, 2020 | -$675.06K | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.36M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.95M | – |
See a number that looks wrong?